ICON And Fountain Medical Development (FMD) Announce Opening Of Laboratory Facility In China
ICON Central Laboratories - a division of ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries – today announced the opening of a new laboratory facility in Tianjin, China, in partnership with Fountain Medical Development Ltd (FMD). It is the third ICON laboratory in the Asia-Pacific region.
ICON Central Laboratories China offers 3000 square feet of laboratory space and is located 70 miles from Beijing in Tianjin – one of China’s most accessible and technologically advanced cities. It will deliver site support services to clinical investigators throughout China and offers overall benefits including shorter shipping distances between clinical sites and existing laboratory testing facilities which expedites study completion.
The facility will offer a comprehensive menu of testing services that includes: chemistry, haematology, coagulation, immunology and other testing services to meet study-specific requirements. The laboratory received CAP (College of American Pathologists) accreditation in May 2010 and is also NGSP Level I Certified.
Commenting on the announcement, Tom O’Leary, President - ICON Central Laboratories, said: “Our alliance with Fountain Medical Development (FMD) and the launch of this new facility underlines our commitment to satisfying our clients’ growing demand for quality central laboratory services in the Asia-Pacific region.”Dan Zheng, CEO, FMD, added: “Partnering with ICON Central Laboratories gives the FMD team access to the resources, systems and infrastructure of a large international organisation involved in the management of both large global trials and localised studies. In return, our local knowledge and experience will be utilised by ICON as they work to provide clients with a faster and more cost efficient service.” ICON has been operational in the Asia-Pacific region for over 10 years, where it already employs over 800 staff, with existing laboratory facilities situated in Bangalore and Singapore. Notes to Editors: About ICON plc: ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently employs over 7,300 employees, operating from 71 locations in 39 countries.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV